Stemtech Corp
STEK- Exchange
- OTC
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0001511820
No open-market purchases or sales by Stemtech Corp insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding STEK, Q2 2026
No superinvestor reported holding STEK at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Stemtech Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2025 (view filing)12:17 PM ET | Jun 23 | 4 daysLate | Kaplan Benjamin NathanielDirector | SSale | −1.00M | $0.03 | −$30.0K | −45.5%1.20M after | |
| Jul 31, 2024 (view filing)4:50 PM ET | Jul 26 | 5 daysLate | Arnold Charles StuartDirector | PPurchaseCOMMON - CREST VENTURES LLC | +25.0K | $0.05 | +$1.25K | +1.4%1.79M after | |
| Apr 22, 2024 (view filing)8:16 PM ET | Apr 19 | 3 days | Mindshare Holdings, Inc.Other: Shareholder - less than 5%. | SSale | −25.0K | $0.0641 | −$1.60K | −1.0%2.43M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Stemtech Corp at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding STEK in 13F filings for Q2 2026.